Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel.

ABSTRACT:

Objective

The aim of this study was to evaluate the QIAstat-Dx® Respiratory SARS-CoV-2 Panel (QIAstat-SARS-CoV-2), which is a closed, fully automated, multiplex polymerase chain reaction (PCR) assay that detects severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and 21 other pathogens that cause respiratory disease.

Methods

Nasopharyngeal swabs from patients with or suspected of having coronavirus disease 2019 were collected and tested at Bichat-Claude Bernard Hospital, Paris, France. Using the World Health Organisation-approved real-time-PCR assay developed by the Charité Institute of Virology as the reference, positive percent agreement (PPA) and negative percent agreement (NPA) were calculated.

Results

In total, 189 negative and 88 positive samples were a

SUBMITTER: Lebourgeois S 

PROVIDER: S-EPMC8064816 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature